Author:
Bennouna Jaafar,Bompas Emmanuelle,Neidhardt Eve Marie,Rolland Frédéric,Philip Irène,Galéa Céline,Salot Samuel,Saiagh Soraya,Audrain Marie,Rimbert Marie,Lafaye-de Micheaux Sylvie,Tiollier Jérôme,Négrier Sylvie
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference24 articles.
1. Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S (2005) Carbonic anhydrase IX expression predicts outcome of interleukin-2 therapy for renal cancer. Clin Cancer Res 11:3714–21
2. Bukowski RM (2001) Cytokine therapy for metastatic renal cell carcinoma. Semin Urol Oncol 19:148–54
3. Common Toxicity Criteria (CTC) (1999) Cancer Therapy Evaluation Program. Common Toxicity Criteria, version 2.0. DCTD, NCI, NIH, DHHS
4. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM; TARGET Study Group (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134
5. Espinosa E, Belmant C, Pont F, Luciani B, Poupot R, Romagné F, Brailly H, Bonneville M, Fournié JJ (2001) Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human γδ T cells. J Biol Chem 276:18337–18344
Cited by
209 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献